Coronary Revascularization and Long-Term Survivorship in Chronic Coronary Syndrome
Authors:
- Ana Gabaldon-PerezAGAna Gabaldon-Perez
- Victor Marcos-GarcesVictor Marcos-Garces
- Jose GavaraJGJose Gavara
- Cesar Rios-NavarroCRCesar Rios-Navarro
- Gema MiñanaGMGema Miñana
- Antoni Bayes-GenisABAntoni Bayes-Genis
- Oliver HusserOHOliver Husser
- Juan SanchisJSJuan Sanchis
- Julio NunezJNJulio Nunez
- Francisco Javier ChorroFCFrancisco Javier Chorro
- Vicente BodiVBVicente Bodi
Open Access
- 5 February 2021
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (4) , 610
Abstract
Ischemic heart disease (IHD) persists as the leading cause of death in the Western world. In recent decades, great headway has been made in reducing mortality due to IHD, based around secondary prevention. The advent of coronary revascularization techniques, first coronary artery bypass grafting (CABG) surgery in the 1960s and then percutaneous coronary intervention (PCI) in the 1970s, has represented one of the major breakthroughs in medicine during the last century. The benefit provided by these techniques, especially PCI, has been crucial in lowering mortality rates in acute coronary syndrome (ACS). However, in the setting where IHD is most prevalent, namely chronic coronary syndrome (CCS), the increase in life expectancy provided by coronary revascularization is controversial. Over more than 40 years, several clinical trials have been carried out comparing optimal medical treatment (OMT) alone with a strategy of routine coronary revascularization on top of OMT. Beyond a certain degree of symptomatic improvement and lower incidence of minor events, routine invasive management has not demonstrated a convincing effect in terms of reducing mortality in CCS. Based on the accumulated evidence more than half a century after the first revascularization procedures were used, invasive management should be considered in those patients with uncontrolled symptoms despite OMT or high-risk features related to left ventricular function, coronary anatomy, or functional assessment, taking into account the patient expectations and preferences.Keywords
Funding Information
- Instituto de Salud Carlos III (PI20/00637, PI17/01836)
- Fondos Europeos de Desarrollo Regional FEDER (CIBERCV16/11/00486, CIBER-CV6/11/00420)
This publication has 100 references indexed in Scilit:
- Prognostic Value of Stress Cardiac Magnetic Resonance Imaging in Patients With Known or Suspected Coronary Artery DiseaseJACC, 2013
- The Prognostic Value of Normal Stress Cardiac Magnetic Resonance in Patients With Known or Suspected Coronary Artery DiseaseCirculation: Cardiovascular Imaging, 2013
- Health Status After Treatment for Coronary Artery Disease and Type 2 Diabetes Mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes TrialCirculation, 2010
- The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart DiseaseCirculation, 2009
- A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery DiseaseNew England Journal of Medicine, 2009
- Valor diagnóstico adicional de la disfunción sistólica inducida para la detección de enfermedad coronaria mediante resonancia magnética cardiaca de estrés con dipiridamolRevista Espanola de Cardiologia, 2009
- Twelve-Year Follow-up of Survival in the Randomized European Coronary Surgery StudyNew England Journal of Medicine, 1988
- Intravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal AngioplastyNew England Journal of Medicine, 1987
- Coronary Bypass for Stable AnginaNew England Journal of Medicine, 1979
- Transluminal Treatment of Arteriosclerotic ObstructionCirculation, 1964